✦ LIBER ✦

Proteasome inhibitor, bortezomib, for myeloma and lymphoma

✍ Scribed by Kensei Tobinai

Publisher: Springer
Year: 2007
Tongue: English
Weight: 246 KB
Volume: 12
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-007-0695-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Proteasome inhibitor bortezomib targeted

Proteasome inhibitor bortezomib targeted tumor–endothelial cell interaction in T-cell leukemia/lymphoma

✍ Wen-Yu Shi; Li Wang; Dan Xiao; Yin Yao; Fan Yang; Xiao-Xing Jiang; Christophe Le 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 420 KB

2-D PAGE-based comparison of proteasome

2-D PAGE-based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphoma

✍ Marc Weinkauf; Yvonne Zimmermann; Elena Hartmann; Andreas Rosenwald; Malte Rieke 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

Proteasome inhibition with bortezomib: A

Proteasome inhibition with bortezomib: A new therapeutic strategy for non-Hodgkin's lymphoma

✍ John P. Leonard; Richard R. Furman; Morton Coleman 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 203 KB

## Abstract The incidence of non‐Hodgkin's lymphoma (NHL) has markedly increased in the US and other westernized countries in recent years and presents a considerable clinical challenge. NHL is divided into subtypes that follow an aggressive or indolent course. Follicular lymphoma (FL), the most co

Synthesis of four isotopically labeled f

Synthesis of four isotopically labeled forms of a proteasome inhibitor, bortezomib

✍ Yuexian Li; Mihaela Plesescu; Patrick Sheehan; J. Scott Daniels; Shimoga R. Prak 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 117 KB

## Abstract [D~2~](1__R__)‐3‐methyl‐1‐[[(2S)‐1‐oxo‐3‐phenyl‐2‐[(pyrazinylcarbonyl)amino]propyl]‐amino]butyl] boronic acid ([D~2~]bortezomib), a proteasome inhibitor, was synthesized in 11 steps from __iso__butyryl chloride. Key steps in the synthesis included formation of the __iso__butyryl boronic

SAHA induces apoptosis in hepatoma cells

SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib

✍ S. Emanuele; M. Lauricella; D. Carlisi; B. Vassallo; A. D’Anneo; P. Di Fazio; R. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 627 KB

The proteasome inhibitor bortezomib dras

The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats

✍ Evangelia Yannaki; Anastasia Papadopoulou; Evangelia Athanasiou; Panayotis Kaloy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 791 KB

## Abstract ## Objective To explore the effect of bortezomib in splenocytes and fibroblast‐like synoviocytes (FLS) and its in vivo potency in a rat model of adjuvant‐induced arthritis (AIA), which resembles human rheumatoid arthritis (RA). ## Methods AIA was induced with Freund's complete adjuva